Orthopedic surgeons frequently face the complex challenge of balancing effective acute pain control with the long-term risk of dependency. Consequently, many medical institutions evaluate whether the specific choice of a first-line opioid medication can influence the development of persistent opioid use after major surgery. Specifically, a recent prospective sequential cohort study investigated this concern by comparing oxycodone and morphine in a large clinical population undergoing orthopedic procedures.

The research analyzed data from over 1,800 patients to determine if switching to morphine as the primary analgesic could mitigate long-term dependency risks. However, the results revealed that both medications led to nearly identical outcomes for patients. Specifically, the rate of new persistent opioid use at the six-month mark was 2.5% for the morphine group and 2.6% for the oxycodone group. Therefore, switching the drug class during hospitalization did not provide a protective benefit against the risk of chronic use.

Mitigating the Risk of Persistent Opioid Use

In addition to dependency risks, clinicians must ensure that analgesic efficacy remains uncompromised when selecting a pain management regimen. Furthermore, the study confirmed that both patient cohorts experienced comparable pain levels at rest upon discharge and during the follow-up period. Moreover, the median daily opioid dose during hospitalization remained consistent across both groups. Thus, morphine serves as a viable analgesic equivalent to oxycodone without significantly altering the risk profile for postoperative complications.

Overall, these findings suggest that the specific type of first-line opioid matters less than the total dose and duration of treatment. Nevertheless, surgeons should focus on multimodal analgesia and strict prescribing limits to improve patient safety. In addition, healthcare providers in India should consider these results when updating institutional protocols for orthopedic recovery. By reducing the volume of opioids prescribed, clinicians can better address the growing concerns regarding surgical recovery and long-term patient health.

What is new persistent opioid use (NPOU)?

New persistent opioid use refers to the continued filling of opioid prescriptions long after the expected period of surgical recovery, typically identified between three to six months postoperatively in previously opioid-naïve patients.

Does morphine perform better than oxycodone for pain?

The study found that morphine and oxycodone provided comparable analgesia during hospitalization and at discharge. Neither drug showed a significant advantage in reducing pain scores at the six-month follow-up.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult a qualified physician for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Melis EJ et al. Effect of oxycodone vs. morphine as first-line opioid on new persistent opioid use after orthopaedic surgery: A prospective sequential cohort study. Br J Clin Pharmacol. 2026 Apr 04. doi: 10.1002/bcp.70551. PMID: 41934202.

Edward KL et al. Systematic review and meta-analysis of opioid use at 3, 6 and 12 months post-operatively by opioid naïve orthopaedic surgery patients. J Opioid Manag. 2021 Nov-Dec;17(6):495-506. doi: 10.5055/jom.2021.0686.

Hah JM et al. Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic. Anesth Analg. 2017 Nov;125(5):1733-1740. doi: 10.1213/ANE.0000000000002458.